Home › Funds › Two Sigma Investments › SAVA
Two Sigma Investments position in SAVA
FILANA THERAPEUTICS INC
Latest position (Q2 2026)1.71M sh
Reported value held$2.04M
Portfolio Weight0.00%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 18.75K | $231.60K | New |
| Q3 2024 | 72.15K | $2.12M | Add |
| Q4 2024 | 562.08K | $1.33M | Add |
| Q1 2025 | 432.58K | $648.87K | Reduce |
| Q1 2025 | 432.58K | $648.87K | Reduce |
| Q2 2025 | 526.51K | $952.99K | Add |
| Q2 2025 | 526.51K | $952.99K | Add |
| Q3 2025 | 565.00K | $1.64M | Add |
| Q4 2025 | 642.40K | $1.27M | Add |
| Q1 2026 | 1.99M | $3.36M | Add |
| Q2 2026 | 1.71M | $2.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SAVA
- Vanguard Group 2.38M sh · $4.70M · Q4 2025
- Marshall Wace 1.60M sh · $1.90M · Q2 2026
- BlackRock Inc 1.45M sh · $1.73M · Q2 2026
- Geode Capital Management 615.51K sh · $732.74K · Q2 2026
- D. E. Shaw & Co 485.02K sh · $577.18K · Q2 2026
- BNY Mellon 20.28K sh · $24.14K · Q2 2026
- JPMorgan Chase & Co 17.03K sh · $20.78K · Q2 2026
- Morgan Stanley 13.56K sh · $16.14K · Q2 2026
- Wells Fargo & Co 10.47K sh · $12.45K · Q2 2026
- Fidelity Management & Research (FMR) 2.90K sh · $3.46K · Q2 2026
- T. Rowe Price Associates 40.86K sh · $49 · Q2 2026